Efficacy and safety of programmed death 1 inhibitors in patients with advanced non-small cell lung cancer: a meta-analysis

Efficacy and safety of programmed death 1 inhibitors in patients with advanced non-small cell lung cancer: a meta-analysis

Yi Liu,1,* Sijing Zhou,2,* Yongsheng Du,3,* Li Sun,1 Huihui Jiang,1 Binbin Zhang,1 Gengyun Sun,1 Ran Wang11Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People’s Republic of China; 2Hefei Prevention and Treat...

Full description

Bibliographic Details
Main Authors: Liu Y, Zhou S, Du Y, Sun L, Jiang H, Zhang B, Sun G, Wang R
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Cancer Management and Research
Subjects:
programmed death 1
lung cancer
efficacy
safety
Online Access:https://www.dovepress.com/efficacy-and-safety-of-programmed-death-1-inhibitors-in-patients-with--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/efficacy-and-safety-of-programmed-death-1-inhibitors-in-patients-with--peer-reviewed-article-CMAR

Similar Items